Haohe Biotechnology (Changzhou) Co., Ltd. (hereinafter referred to as Haohe Biotechnology), formerly known as Nanjing Haohe Biotechnology Co., Ltd., was established in May 2021. At the beginning of its establishment, the company received tens of millions of dollars of angel round investment from Singapore. In May 2024, China State Investment High-tech Industry Investment Co., Ltd. (hereinafter referred to as State Investment High-tech) made an industrial investment in our company. This project is the first time that State Investment High-tech has invested in an incubated technology enterprise. Haohe biological adhering to the natural, healthy, low-carbon concept, is committed to high natural degree, high optical purity, high chemical purity of the product development. It has core technologies such as microbial strain selection and precise fermentation control, and has established a variety of green biological manufacturing technology systems such as bulk chemicals and fine chemicals. The company has realized the production of L-malic acid by one-step fermentation with renewable sugar as raw material, and obtained high-quality products; developed a product matrix with L-malic acid as the core platform compound, and expanded its application in food, medicine, electronics, chemical industry and other fields.